This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR, bead-based and microplate assays and next-generation sequencing. Further this market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer’s disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics market has phenomenally increased the volume and quality of diagnostic procedures by reducing the turnaround time and analyzing multiple analytes in a single cycle and thereby resulting in rapid adoption of such techniques. The stake holders in this market include market players who provide multiplexed diagnostic assay kits, reagents, solutions and systems.
This research report provides a detailed analysis of the global multiplexed diagnostics market and also covers the various driving factors which are responsible for the growth of this market. The executive summary comprises the market snapshot which gives details about various segments and sub-segments, and also includes the comparative analysis of the multiplexed diagnostics market according to its segmentation. The qualitative details of the market dynamics of the multiplexed diagnostics market such as drivers, restraints and opportunities that influence the current nature and future status of this field are covered under the market overview section of this report. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been provided in the market overview section of the report in order to give a thorough analysis of the overall competitive scenario in the global multiplexed diagnostics market. All these factors would help the market players to gain thorough analysis of the overall competitive scenario and thereby decide upon the business strategies and plans to be incurred in future for sustaining and growing in the global multiplexed diagnostics market.
The global multiplexed diagnostics market is classified based on the types of technology, application and geography. The market size and estimates from 2011 to 2019 for each of these segments is provided in USD million in this report. The multiplexed diagnostics market based on the type of technology is segmented into very high density multiplexed assays, high density multiplexed assays, medium density multiplexed assays, low density multiplexed assays, and next generation sequencing assays. Furthermore, based on the type of applications, the market is characterized into infectious disease diagnosis, oncology, autoimmune disease, cardiac, allergies and others. A detailed market analysis of the above segments has been provided in this study, based on their market size and forecast in terms of USD million for the period 2011 to 2019. The compounded annual growth rate (CAGR %) has been estimated for the period 2013 to 2019, considering 2012 as the base year.
In terms of geographical distribution, the global multiplexed diagnostics market has been categorized into four geographical regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). This section further includes the market size and forecast of the mentioned regional markets for the period 2011 to 2019 along with their growth rates. This report also includes strategic recommendations, which would be useful for the current and future market players to sustain, grow and establish position in the global multiplexed diagnostics market.
This report concludes with the company profiles section which comprises key information such as company overview, financial overview, product portfolio, business strategies, and recent developments about the major players in multiplexed diagnostics market. Some of the key players profiled in this report include Affymetrix, Agilent Technologies, Gen-Probe, Inc., bioMerieux, Life Technologies, Luminex Corporation and Illumina, Inc.